ORFIRIL sol inj 300 mg/3ml amp 5 pce

7680543310106 CH-54331 N03AG01 01.07.1.
ORFIRIL sol inj 300 mg/3ml amp 5 pce
ORFIRIL sol inj 300 mg/3ml amp 5 pce
ORFIRIL sol inj 300 mg/3ml amp 5 pce
1 / 3
google

Details

Product number
5433101
CPT
-
Packaging group
5
Unit
Ampulle(n)
Composition
natrii valproas 300 mg, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 3 ml.

Articles (1)

Orfiril 300mg/3mL, Injektionslösung
Injektionslösung
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
05/07/2025
Professional SmPC
Français
05/07/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
acidum valproicum
260.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum concentratum
- Substance HNIDK
(N/A)
- Substance HNIDK
natrium
41.65 MG Substance HBESI

Authorization holder

Desitin Pharma GmbH

4410 Liestal

Authorization information

Swissmedic authorization number
54331
Drug name
Orfiril, Injektionslösung
Galenic form
LSPA
ATC Code
N03AG01
Authorization status
Z
Dispensation category
B
First authorization
19/11/1998
Authorization expiration date
31/12/9999
IT number
01.07.1.
Domain
Human medicine
Field of application
Antiepileptikum

Packaging details

Description (FR)
ORFIRIL sol inj 300 mg/3ml amp 5 pce
Description (DE)
ORFIRIL Inj Lös 300 mg/3ml Amp 5 Stk
Market launch
19/11/1998
Narcotic (BTM)
No

Available generics

Orfiril, Sirup
CHF 26.00
View
Valproat chrono Desitin, Retardtabletten
CHF 25.90
View
Valproat chrono Desitin, Retardtabletten
CHF 26.65
View
Valproate Chrono Sanofi, comprimés à libération prolongée
CHF 26.05
View
Valproate Chrono Sanofi, comprimés à libération prolongée
CHF 26.65
View
Valproat Sandoz, Retardtabletten
CHF 25.90
View
Valproat Sandoz, Retardtabletten
CHF 26.65
View

Other packaging sizes